These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10582786)

  • 21. Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment.
    Fulghesu AM; Apa R; Belosi C; Ciampelli M; Selvaggi L; Cucinelli F; Caruso A; Mancuso S; Lanzone A
    Horm Res; 2001; 55(5):224-8. PubMed ID: 11740143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment options of clomiphene-resistant polycystic ovary syndrome related infertility].
    Liang X; Zhuang G; Zhou C
    Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):591-3. PubMed ID: 11372407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone.
    Kamrava MM; Seibel MM; Berger MJ; Thompson I; Taymor ML
    Fertil Steril; 1982 Apr; 37(4):520-3. PubMed ID: 6802679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction.
    Serour GI; Aboulghar M; Al Bahar A; Hugues JN; Esmat K
    Reprod Biol Endocrinol; 2014 Jun; 12():52. PubMed ID: 24942155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study.
    Yarali H; Bukulmez O; Gurgan T
    Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review.
    van Wely M; Bayram N; van der Veen F
    Hum Reprod; 2003 Jun; 18(6):1143-9. PubMed ID: 12773438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Value of Elevated LH/FSH Ratio for Ovulation Induction in Patients with Polycystic Ovary Syndrome.
    Woo I; Tobler K; Khafagy A; Christianson MS; Yates M; Garcia J
    J Reprod Med; 2015; 60(11-12):495-500. PubMed ID: 26775457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A randomized, single-blind, parallel-controlled and multicentre study: compare the efficacy and safety of domestic and imported human recombinant FSH in WHO group Ⅱ anovulatory infertility].
    Zhou YZ; Shen H; Zuo WL; Xu YH; Deng XH; Chen YL; Gao Y; Wang XX; Xu W; Lai QH; Shi H; Liu W; He Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):258-63. PubMed ID: 27116983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome.
    Balasch J; Fábregues F; Casamitjana R; Peñarrubia J; Vanrell JA
    Reprod Biomed Online; 2003; 6(3):296-301. PubMed ID: 12735863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.
    Borm G; Mannaerts B
    Hum Reprod; 2000 Jul; 15(7):1490-8. PubMed ID: 10875855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists.
    Frydman R; Howles CM; Truong F
    Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of clomiphene citrate-resistant polycystic ovarian syndrome with pure follicle-stimulating hormone or human menopausal gonadotropin.
    McFaul PB; Traub AI; Thompson W
    Fertil Steril; 1990 May; 53(5):792-7. PubMed ID: 2110070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First established pregnancy and birth after induction of ovulation with recombinant human follicle-stimulating hormone in polycystic ovary syndrome.
    van Dessel HJ; Donderwinkel PF; Coelingh Bennink HJ; Fauser BC
    Hum Reprod; 1994 Jan; 9(1):55-6. PubMed ID: 8195351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction.
    Muenstermann U; Kleinstein J
    Hum Reprod; 2000 Dec; 15(12):2526-30. PubMed ID: 11098021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The choice of treatment for anovulation associated with polycystic ovary syndrome following failure to conceive with clomiphene.
    Farhi J; Homburg R; Lerner A; Ben-Rafael Z
    Hum Reprod; 1993 Sep; 8(9):1367-71. PubMed ID: 8253919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S; Pigny P; Reyss AC; Decanter C; Poncelet E; Dewailly D
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.